ID

41079

Beschreibung

Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01421862

Link

https://clinicaltrials.gov/show/NCT01421862

Stichworte

  1. 20.06.20 20.06.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

20. Juni 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Leukemia NCT01421862

Eligibility Leukemia NCT01421862

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01421862
Criteria
Beschreibung

Criteria

samples from previously untreated non-m3 acute myeloid leukemia (aml)
Beschreibung

Specimen AML Untreated | Exception Acute Promyelocytic Leukemia

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0370003
UMLS CUI [1,2]
C0023467
UMLS CUI [1,3]
C0332155
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0023487
normal karyotype (nk) intermediate-risk disease
Beschreibung

Normal karyotype | Disease Intermediate Risk

Datentyp

boolean

Alias
UMLS CUI [1]
C0333684
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C3640764
two or more vials of cryopreserved pretreatment bone marrow cells and/or two or more vials of cryopreserved pretreatment blood cells available from the intergroup aml repository
Beschreibung

Bone Marrow Cells Pretreatment Cryopreserved | Blood Cells Pretreatment Cryopreserved

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005955
UMLS CUI [1,2]
C3539075
UMLS CUI [1,3]
C0010405
UMLS CUI [2,1]
C0005773
UMLS CUI [2,2]
C3539075
UMLS CUI [2,3]
C0010405
blast count ≥ 60%
Beschreibung

Blast count

Datentyp

boolean

Alias
UMLS CUI [1]
C0523113
eligible and evaluable for the patient's clinical trial, and did not have fatal induction toxicity
Beschreibung

Eligibility Clinical Trial | Evaluable Patient Clinical Trial | Toxicity Fatal Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1548635
UMLS CUI [1,2]
C0008976
UMLS CUI [2,1]
C2986511
UMLS CUI [2,2]
C0008976
UMLS CUI [3,1]
C0600688
UMLS CUI [3,2]
C1302234
UMLS CUI [3,3]
C0332197
response to protocol induction chemotherapy:
Beschreibung

Response Induction Chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1704632
UMLS CUI [1,2]
C3179010
non-response: aml with failure to achieve a complete remission (cr) after induction chemotherapy ("7 & 3"-based therapy using cytatabine and/or daunorobicin hydrochloride (dnr) or idarubicin and/or dnr
Beschreibung

Therapy non-responder | Complete remission failed | Status post Induction Chemotherapy | Cytarabine | Daunorubicin Hydrochloride | Idarubicin

Datentyp

boolean

Alias
UMLS CUI [1]
C0919875
UMLS CUI [2,1]
C0677874
UMLS CUI [2,2]
C0231175
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C3179010
UMLS CUI [4]
C0010711
UMLS CUI [5]
C0282123
UMLS CUI [6]
C0020789
responders: continued complete remission (ccr) > 2 years
Beschreibung

Therapy responder | Continued Complete Response

Datentyp

boolean

Alias
UMLS CUI [1]
C0919876
UMLS CUI [2]
C2347861
patient characteristics:
Beschreibung

Patient Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
not specified
Beschreibung

Unspecified

Datentyp

boolean

Alias
UMLS CUI [1]
C0205370
prior concurrent therapy:
Beschreibung

Prior Therapy Concurrent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0205420
see disease characteristics
Beschreibung

ID.12

Datentyp

boolean

Ähnliche Modelle

Eligibility Leukemia NCT01421862

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01421862
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Specimen AML Untreated | Exception Acute Promyelocytic Leukemia
Item
samples from previously untreated non-m3 acute myeloid leukemia (aml)
boolean
C0370003 (UMLS CUI [1,1])
C0023467 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0023487 (UMLS CUI [2,2])
Normal karyotype | Disease Intermediate Risk
Item
normal karyotype (nk) intermediate-risk disease
boolean
C0333684 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C3640764 (UMLS CUI [2,2])
Bone Marrow Cells Pretreatment Cryopreserved | Blood Cells Pretreatment Cryopreserved
Item
two or more vials of cryopreserved pretreatment bone marrow cells and/or two or more vials of cryopreserved pretreatment blood cells available from the intergroup aml repository
boolean
C0005955 (UMLS CUI [1,1])
C3539075 (UMLS CUI [1,2])
C0010405 (UMLS CUI [1,3])
C0005773 (UMLS CUI [2,1])
C3539075 (UMLS CUI [2,2])
C0010405 (UMLS CUI [2,3])
Blast count
Item
blast count ≥ 60%
boolean
C0523113 (UMLS CUI [1])
Eligibility Clinical Trial | Evaluable Patient Clinical Trial | Toxicity Fatal Absent
Item
eligible and evaluable for the patient's clinical trial, and did not have fatal induction toxicity
boolean
C1548635 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C2986511 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0600688 (UMLS CUI [3,1])
C1302234 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
Response Induction Chemotherapy
Item
response to protocol induction chemotherapy:
boolean
C1704632 (UMLS CUI [1,1])
C3179010 (UMLS CUI [1,2])
Therapy non-responder | Complete remission failed | Status post Induction Chemotherapy | Cytarabine | Daunorubicin Hydrochloride | Idarubicin
Item
non-response: aml with failure to achieve a complete remission (cr) after induction chemotherapy ("7 & 3"-based therapy using cytatabine and/or daunorobicin hydrochloride (dnr) or idarubicin and/or dnr
boolean
C0919875 (UMLS CUI [1])
C0677874 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C3179010 (UMLS CUI [3,2])
C0010711 (UMLS CUI [4])
C0282123 (UMLS CUI [5])
C0020789 (UMLS CUI [6])
Therapy responder | Continued Complete Response
Item
responders: continued complete remission (ccr) > 2 years
boolean
C0919876 (UMLS CUI [1])
C2347861 (UMLS CUI [2])
Patient Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Prior Therapy Concurrent
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
ID.12
Item
see disease characteristics
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video